OBJECTIVE: To analyse the epidemiological evolution of cryptococcosis in France after the introduction of highly active antiretroviral therapy (HAART). DESIGN: Retrospective study of cryptococcosis cases recorded at the National Reference Center for Mycoses in France since 1985. METHODS: Using the national surveillance data, we reviewed 1644 cases of HIV-associated cryptococcosis diagnosed in France (population, 59 million) between 1985 and 2001 and compared them to 335 cases recorded in HIV-negative patients. RESULTS: The total number of cryptococcosis cases evolved in parallel to that recorded for HIV-infected patients. Changes occurring after HAART introduction were analysed. A negative binomial regression model established a 46% decrease of the incidence of cryptococcosis during the post-HAART era (1997-2001, n = 292) compared to the pre-HAART era (1985-1996, n = 1352). According to multivariate analysis, African origin, older age, heterosexual HIV contamination, no previous AIDS-defining illness, and no previous HIV infection diagnosis were variables independently associated with an increased risk of cryptococcosis during the post-HAART era. During the same period, the characteristics of the HIV-negative population did not change. CONCLUSIONS: Our analysis of the national surveillance identified demographic factors associated with an increased risk of cryptococcosis in the post-HAART era suggesting that failure to consult and considering oneself not at risk were determinant in the current epidemiology of HIV-related cryptococcosis in France.
OBJECTIVE: To analyse the epidemiological evolution of cryptococcosis in France after the introduction of highly active antiretroviral therapy (HAART). DESIGN: Retrospective study of cryptococcosis cases recorded at the National Reference Center for Mycoses in France since 1985. METHODS: Using the national surveillance data, we reviewed 1644 cases of HIV-associated cryptococcosis diagnosed in France (population, 59 million) between 1985 and 2001 and compared them to 335 cases recorded in HIV-negative patients. RESULTS: The total number of cryptococcosis cases evolved in parallel to that recorded for HIV-infectedpatients. Changes occurring after HAART introduction were analysed. A negative binomial regression model established a 46% decrease of the incidence of cryptococcosis during the post-HAART era (1997-2001, n = 292) compared to the pre-HAART era (1985-1996, n = 1352). According to multivariate analysis, African origin, older age, heterosexual HIV contamination, no previous AIDS-defining illness, and no previous HIV infection diagnosis were variables independently associated with an increased risk of cryptococcosis during the post-HAART era. During the same period, the characteristics of the HIV-negative population did not change. CONCLUSIONS: Our analysis of the national surveillance identified demographic factors associated with an increased risk of cryptococcosis in the post-HAART era suggesting that failure to consult and considering oneself not at risk were determinant in the current epidemiology of HIV-related cryptococcosis in France.
Authors: E Dannaoui; M Abdul; M Arpin; A Michel-Nguyen; M A Piens; A Favel; O Lortholary; F Dromer Journal: Antimicrob Agents Chemother Date: 2006-07 Impact factor: 5.191
Authors: Rosalind Parkes-Ratanshi; Katie Wakeham; Jonathan Levin; Deodata Namusoke; James Whitworth; Alex Coutinho; Nathan Kenya Mugisha; Heiner Grosskurth; Anatoli Kamali; David G Lalloo Journal: Lancet Infect Dis Date: 2011-10-06 Impact factor: 25.071
Authors: George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim Journal: Pediatr Infect Dis J Date: 2013-11 Impact factor: 2.129
Authors: Massimo Cogliati; Roberta D'Amicis; Alberto Zani; Maria Teresa Montagna; Giuseppina Caggiano; Osvalda De Giglio; Stella Balbino; Antonella De Donno; Francesca Serio; Serdar Susever; Cagri Ergin; Aristea Velegraki; Mohamed S Ellabib; Simona Nardoni; Cristina Macci; Salvatore Oliveri; Laura Trovato; Ludovico Dipineto; Volker Rickerts; Ilka McCormick-Smith; Sevim Akcaglar; Okan Tore; Emilija Mlinaric-Missoni; Sebastien Bertout; Michele Mallié; Maria da Luz Martins; Ana C F Vencà; Maria L Vieira; Ana C Sampaio; Cheila Pereira; Giuseppe Criseo; Orazio Romeo; Stéphane Ranque; Mohammed H Y Al-Yasiri; Meltem Kaya; Nilgun Cerikcioglu; Anna Marchese; Luigi Vezzulli; Macit Ilkit; Marie Desnos-Ollivier; Vincenzo Pasquale; Maya Korem; Itzhack Polacheck; Antonio Scopa; Wieland Meyer; Kennio Ferreira-Paim; Ferry Hagen; Bart Theelen; Teun Boekhout; Shawn R Lockhart; Kathrin Tintelnot; Anna Maria Tortorano; Françoise Dromer; Ashok Varma; Kyung J Kwon-Chung; Joäo Inácio; Beatriz Alonso; Maria F Colom Journal: FEMS Yeast Res Date: 2016-05-05 Impact factor: 2.796